These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23328114)

  • 1. Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.
    Mohan P; Castellsague J; Jiang J; Allen K; Chen H; Nemirovsky O; Spyra M; Hu K; Kluwe L; Pujana MA; Villanueva A; Mautner VF; Keats JJ; Dunn SE; Lazaro C; Maxwell CA
    Oncotarget; 2013 Jan; 4(1):80-93. PubMed ID: 23328114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.
    Patel AV; Eaves D; Jessen WJ; Rizvi TA; Ecsedy JA; Qian MG; Aronow BJ; Perentesis JP; Serra E; Cripe TP; Miller SJ; Ratner N
    Clin Cancer Res; 2012 Sep; 18(18):5020-30. PubMed ID: 22811580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial regulation of Aurora A activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2.
    Chen H; Mohan P; Jiang J; Nemirovsky O; He D; Fleisch MC; Niederacher D; Pilarski LM; Lim CJ; Maxwell CA
    Cell Cycle; 2014; 13(14):2248-61. PubMed ID: 24875404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.
    Sehdev V; Peng D; Soutto M; Washington MK; Revetta F; Ecsedy J; Zaika A; Rau TT; Schneider-Stock R; Belkhiri A; El-Rifai W
    Mol Cancer Ther; 2012 Mar; 11(3):763-74. PubMed ID: 22302096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
    Maxwell CA; Benítez J; Gómez-Baldó L; Osorio A; Bonifaci N; Fernández-Ramires R; Costes SV; Guinó E; Chen H; Evans GJ; Mohan P; Català I; Petit A; Aguilar H; Villanueva A; Aytes A; Serra-Musach J; Rennert G; Lejbkowicz F; Peterlongo P; Manoukian S; Peissel B; Ripamonti CB; Bonanni B; Viel A; Allavena A; Bernard L; Radice P; Friedman E; Kaufman B; Laitman Y; Dubrovsky M; Milgrom R; Jakubowska A; Cybulski C; Gorski B; Jaworska K; Durda K; Sukiennicki G; Lubiński J; Shugart YY; Domchek SM; Letrero R; Weber BL; Hogervorst FB; Rookus MA; Collee JM; Devilee P; Ligtenberg MJ; Luijt RB; Aalfs CM; Waisfisz Q; Wijnen J; Roozendaal CE; ; ; Easton DF; Peock S; Cook M; Oliver C; Frost D; Harrington P; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Eccles D; Douglas F; Brewer C; Nevanlinna H; Heikkinen T; Couch FJ; Lindor NM; Wang X; Godwin AK; Caligo MA; Lombardi G; Loman N; Karlsson P; Ehrencrona H; Wachenfeldt Av; ; Barkardottir RB; Hamann U; Rashid MU; Lasa A; Caldés T; Andrés R; Schmitt M; Assmann V; Stevens K; Offit K; Curado J; Tilgner H; Guigó R; Aiza G; Brunet J; Castellsagué J; Martrat G; Urruticoechea A; Blanco I; Tihomirova L; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; ; Schmutzler RK; Wappenschmidt B; Meindl A; Arnold N; Deissler H; Varon-Mateeva R; Sutter C; Niederacher D; Imyamitov E; Sinilnikova OM; Stoppa-Lyonne D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon YJ; Uhrhammer N; Peyrat JP; Vennin P; Fert Ferrer S; Collonge-Rame MA; Mortemousque I; ; Spurdle AB; Beesley J; Chen X; Healey S; ; Barcellos-Hoff MH; Vidal M; Gruber SB; Lázaro C; Capellá G; McGuffog L; Nathanson KL; Antoniou AC; Chenevix-Trench G; Fleisch MC; Moreno V; Pujana MA
    PLoS Biol; 2011 Nov; 9(11):e1001199. PubMed ID: 22110403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.
    Shigeishi H; Fujimoto S; Hiraoka M; Ono S; Taki M; Ohta K; Higashikawa K; Kamata N
    Int J Oncol; 2009 Jun; 34(6):1565-71. PubMed ID: 19424574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytoskeletal protein RHAMM and ERK1/2 activity maintain the pluripotency of murine embryonic stem cells.
    Jiang J; Mohan P; Maxwell CA
    PLoS One; 2013; 8(9):e73548. PubMed ID: 24019927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP).
    Maris JM; Morton CL; Gorlick R; Kolb EA; Lock R; Carol H; Keir ST; Reynolds CP; Kang MH; Wu J; Smith MA; Houghton PJ
    Pediatr Blood Cancer; 2010 Jul; 55(1):26-34. PubMed ID: 20108338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
    Blanco I; Kuchenbaecker K; Cuadras D; Wang X; Barrowdale D; de Garibay GR; Librado P; Sánchez-Gracia A; Rozas J; Bonifaci N; McGuffog L; Pankratz VS; Islam A; Mateo F; Berenguer A; Petit A; Català I; Brunet J; Feliubadaló L; Tornero E; Benítez J; Osorio A; Ramón y Cajal T; Nevanlinna H; Aittomäki K; Arun BK; Toland AE; Karlan BY; Walsh C; Lester J; Greene MH; Mai PL; Nussbaum RL; Andrulis IL; Domchek SM; Nathanson KL; Rebbeck TR; Barkardottir RB; Jakubowska A; Lubinski J; Durda K; Jaworska-Bieniek K; Claes K; Van Maerken T; Díez O; Hansen TV; Jønson L; Gerdes AM; Ejlertsen B; de la Hoya M; Caldés T; Dunning AM; Oliver C; Fineberg E; Cook M; Peock S; McCann E; Murray A; Jacobs C; Pichert G; Lalloo F; Chu C; Dorkins H; Paterson J; Ong KR; Teixeira MR; ; Hogervorst FB; van der Hout AH; Seynaeve C; van der Luijt RB; Ligtenberg MJ; Devilee P; Wijnen JT; Rookus MA; Meijers-Heijboer HE; Blok MJ; van den Ouweland AM; Aalfs CM; Rodriguez GC; Phillips KA; Piedmonte M; Nerenstone SR; Bae-Jump VL; O'Malley DM; Ratner ES; Schmutzler RK; Wappenschmidt B; Rhiem K; Engel C; Meindl A; Ditsch N; Arnold N; Plendl HJ; Niederacher D; Sutter C; Wang-Gohrke S; Steinemann D; Preisler-Adams S; Kast K; Varon-Mateeva R; Gehrig A; Bojesen A; Pedersen IS; Sunde L; Jensen UB; Thomassen M; Kruse TA; Foretova L; Peterlongo P; Bernard L; Peissel B; Scuvera G; Manoukian S; Radice P; Ottini L; Montagna M; Agata S; Maugard C; Simard J; Soucy P; Berger A; Fink-Retter A; Singer CF; Rappaport C; Geschwantler-Kaulich D; Tea MK; Pfeiler G; ; John EM; Miron A; Neuhausen SL; Terry MB; Chung WK; Daly MB; Goldgar DE; Janavicius R; Dorfling CM; van Rensburg EJ; Fostira F; Konstantopoulou I; Garber J; Godwin AK; Olah E; Narod SA; Rennert G; Paluch SS; Laitman Y; Friedman E; ; Liljegren A; Rantala J; Stenmark-Askmalm M; Loman N; Imyanitov EN; Hamann U; ; Spurdle AB; Healey S; Weitzel JN; Herzog J; Margileth D; Gorrini C; Esteller M; Gómez A; Sayols S; Vidal E; Heyn H; ; Stoppa-Lyonnet D; Léoné M; Barjhoux L; Fassy-Colcombet M; de Pauw A; Lasset C; Ferrer SF; Castera L; Berthet P; Cornelis F; Bignon YJ; Damiola F; Mazoyer S; Sinilnikova OM; Maxwell CA; Vijai J; Robson M; Kauff N; Corines MJ; Villano D; Cunningham J; Lee A; Lindor N; Lázaro C; Easton DF; Offit K; Chenevix-Trench G; Couch FJ; Antoniou AC; Pujana MA
    PLoS One; 2015; 10(4):e0120020. PubMed ID: 25830658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo.
    Zhou N; Singh K; Mir MC; Parker Y; Lindner D; Dreicer R; Ecsedy JA; Zhang Z; Teh BT; Almasan A; Hansel DE
    Clin Cancer Res; 2013 Apr; 19(7):1717-28. PubMed ID: 23403633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.
    Görgün G; Calabrese E; Hideshima T; Ecsedy J; Perrone G; Mani M; Ikeda H; Bianchi G; Hu Y; Cirstea D; Santo L; Tai YT; Nahar S; Zheng M; Bandi M; Carrasco RD; Raje N; Munshi N; Richardson P; Anderson KC
    Blood; 2010 Jun; 115(25):5202-13. PubMed ID: 20382844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR.
    Hatano H; Shigeishi H; Kudo Y; Higashikawa K; Tobiume K; Takata T; Kamata N
    Lab Invest; 2011 Mar; 91(3):379-91. PubMed ID: 20956971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
    Kolberg M; Bruun J; Murumägi A; Mpindi JP; Bergsland CH; Høland M; Eilertsen IA; Danielsen SA; Kallioniemi O; Lothe RA
    Mol Oncol; 2017 Sep; 11(9):1156-1171. PubMed ID: 28556483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer.
    Carol H; Boehm I; Reynolds CP; Kang MH; Maris JM; Morton CL; Gorlick R; Kolb EA; Keir ST; Wu J; Wozniak AE; Yang Y; Manfredi M; Ecsedy J; Wang J; Neale G; Houghton PJ; Smith MA; Lock RB
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1291-304. PubMed ID: 21448591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients.
    Kahl I; Mense J; Finke C; Boller AL; Lorber C; Győrffy B; Greve B; Götte M; Espinoza-Sánchez NA
    J Cell Biochem; 2022 Mar; 123(3):581-600. PubMed ID: 35014077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237.
    Sloane DA; Trikic MZ; Chu ML; Lamers MB; Mason CS; Mueller I; Savory WJ; Williams DH; Eyers PA
    ACS Chem Biol; 2010 Jun; 5(6):563-76. PubMed ID: 20426425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-β.
    Ohishi J; Aoki M; Nabeshima K; Suzumiya J; Takeuchi T; Ogose A; Hakozaki M; Yamashita Y; Iwasaki H
    BMC Cancer; 2013 May; 13():224. PubMed ID: 23642185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2.
    Zeng K; Bastos RN; Barr FA; Gruneberg U
    J Cell Biol; 2010 Dec; 191(7):1315-32. PubMed ID: 21187329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
    Byer SJ; Eckert JM; Brossier NM; Clodfelder-Miller BJ; Turk AN; Carroll AJ; Kappes JC; Zinn KR; Prasain JK; Carroll SL
    Neuro Oncol; 2011 Jan; 13(1):28-41. PubMed ID: 21075781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.
    Mahller YY; Vaikunth SS; Currier MA; Miller SJ; Ripberger MC; Hsu YH; Mehrian-Shai R; Collins MH; Crombleholme TM; Ratner N; Cripe TP
    Mol Ther; 2007 Feb; 15(2):279-86. PubMed ID: 17235305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.